Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Who bought that single CANB share today? LOL Maybe paint it EOD tomorrow with a 2 share buy. Hahahahahaha
Peace out
MISLEADING!!! Maybe 3rd RS for CANB SHIT SHOW?
Someone bought another single share today. There goes the beer money.
PEACE OUT!
Misleading….just like the going out of business Opinion 3 years ago. Buyers will not be fooled so easily.
Nasdaq Cometh
No NASDAQ, bleeding out and another RS may be needed soon. LOL CANB is now officially a massive "SHIT SHOW" and nothing can stop the losses.
Buyer beware as the true value pre-RS is now .0002.
Peace out
So True, LOL!
:
399 shares sold is now a "bleeding out" catastrophe?? LMAO!
I can't make this comedy up, folks
OMG! THE SKY IS FALLING!!! LMAO AGAIN!
Pfffff
NASDAQ
CANB
399 shares sold is now a "bleeding out" catastrophe?? LMAO!
I can't make this comedy up, folks
OMG! THE SKY IS FALLING!!! LMAO AGAIN!
Pfffff
NASDAQ
CANB
The Badguy
CANB now bleeding out for the 3rd time and not sure CANB can get another RS. True share holder value pre-RS is now .0002.
This is a poster child for the OTC cesspool and what it does.
Peace out.
Someone bought 1 share of CANB today. Hahahahahaha Nobody wants anything to do with the triple RS insider cash machine.
NASTY with the MASSIVE debt, bloated salaries and products few want.
Peace out
Up 11.5% today. Welcome to the CANB bd. Here’s the Unbiased Quarterly article to catch up on why Smart Money keeps loading up monthly.
:
THE HIGHEST QUARTERLY REVENUE IN COMPANY HISTORY, Very Impressive Indeed:
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
May 18 2022 - 07:26AM
InvestorsHub NewsWire
Alert
Print
Share On Facebook
Strengthened Balance Sheet with Increases to $17.0 Million in Total Assets and $6.2 Million in Stockholders Equity
HICKSVILLE, NY -- May 18, 2022 -- InvestorsHub NewsWire -- Can B Corp. (OTCQB: CANB) (“Can B'' or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, today announced the Company's financial results for the first quarter ended March 31, 2022.
Key Financial Highlights for Q1 2022
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
Solidified and integrated vertical processing capabilities from recent acquisitions
Advanced build-out of first CBD lounge in Miami, Florida
Continuing path for potential NASDAQ up-listing
Management Commentary
Marco Alfonsi, Can B’s Chief Executive Officer, stated, “We are extremely pleased with our tremendous quarterly results, having achieved the highest quarterly revenue in our company history. We generated the $1.9 million in quarterly revenue while reducing our cash burn as demonstrated by the decrease in adjusted EBITDA to $0.9 million. The strategic moves we have made over the past several months have completed our vertical processing capabilities and put us in great position to accelerate our revenue growth and strengthen our balance sheet. This quarter’s results prove our plans are working as our team continues its hard at work integrating and ramping up the various operations to continue this momentum into the future.”
Alfonsi concluded, “Can B is now a full-service hemp-derived cannabinoid company that can facilitate servicing the large box types as well as the boutique vape and smoke store. Our dramatic revenue improvements, coupled with our acquisitions and asset base increases, position us solidly to continue our application process for a NASDA up listing.”
Vertical Processing Capabilities
Secured hemp biomass and winterized crude to create over 13,000 Liters (1 Liter = 1.05 Quarts) of isomers, including Delta-8, with a potential wholesale value exceeding $10 million at today's market price. Can B's late 2021 acquired facilities in Colorado will receive harvested hemp biomass and convert it to winterized crude. These same facilities will then process it to distillate, then to isolate which will be shipped to Company-owned facilities in Florida and Tennessee to produce Delta-8 or other isomers, or to its manufacturing facility in Lacey, Washington for its line of CBD tinctures, salves, gels, and drops. This processing is expected to take 5-6 months to produce 13,000 liters of Delta-8 and other isomers with potential revenue of $10 million.
300,000 Square Foot Facility in McMinnville, Tennessee
Acquisition of Assets from TWS Pharma included leases on a total of 15,000 square foot of facilities located in Mead and Ft. Morgan Colorado.
Acquisition of Assets from Music City Botanicals added additional volume in extraction, isomer lab production, and R&D into the evolving isomer market with such products as Delta-10, CBG, CBN, and CBDA.
Financial Results for the Three Months Ended March 31, 2022:
Revenue: For the three months ended March 31, 2022, revenue was $1.9 million, an increase of $1.6 million, or 606%, compared with $0.3 million for the same period last year. The increase is due to the wind-down of restrictions related to the Covid-19 Pandemic surrounding elective surgeries, enabling an increase in the usage of the Company’s Duramed product lines and ultrasound device associated with patient recovery. Additionally, due to asset acquisitions in 2021, the Company’s Music City Botanical and Botanical Biotech brands related to an increase in sales compared to 2021 of $0.6 million.
Gross Profit: For the three months ended March 31, 2022, gross profit was $0.7 million, an increase of $0.4 million, or 291%, compared with $0.2 million for the same period last year. The resulting gross margin was 36.0%, compared with 75.0% for the same period last year.
Total Operating Expenses: For the three months ended March 31, 2022, total operating expenses were $3.9 million, an increase of $1.8 million, or 91%, compared with $2.0 million for the same period last year, as a direct result of professional fees and other accounting and legal fees related to the Company’s registration statement S-1 filing efforts.
Of note, $2.3 million of the Company's operating expenses for the three months ended March 31, 2022, were non-cash expenses, including depreciation, amortization, and stock-based compensation, compared to $0.5 million for the same period last year.
Operating Loss: For the three months ended March 31, 2022, operating loss was $3.2 million, an increase of $1.4 million, compared with an operating loss of $1.8 million for the same period last year.
Adjusted EBITDA Loss: For the three months ended March 31, 2022, Adjusted EBITDA loss was $0.9 million, a decrease of $0.4 million, or 30%, compared with an Adjusted EBITDA loss of $1.3 million for the same period last year, after deducting non-cash and one-time expenses.
Net Loss: For the three months ended March 31, 2022, net loss was $3.5 million, an increase of $1.3 million, or 60%, compared with $2.2 million for the same period last year. The EPS loss per share for the three months ended March 31, 2022, was ($1.10), compared to ($3.58) for the same period last year.
About Can B Corp.
Can B Corp. (OTCQB: CANB) is a health & wellness company providing the highest quality hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high-quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Twitter @CanBCorp
Instagram @canbcorp
Facebook @ Can B Corp
YouTube
Maybe a 3rd CANB RS will help. Seems the past 2 RS's did not do the trick.
Much lower and they will not be able to say they are listing on NASDAQ. Guess that was all smoke and mirrors as everyone thought it was.
Peace out
Smart people are selling.
How can this stock be down 21% in one day? I thought smart people were buying.
Who forgot to paint the CANB shit show? Someone better not forget Monday!
Hahahahaha
Peace out
Down 21% today. A win for the promo team!
Cudda been worse.
CANB true pre-RS value is now .0002. LOOK OUT BELOW!
House of cards is ready to fall. Watch for EOD paint as the desperation will soon set in.
Peace out
Who would buy this CANB train wreck? Its a house of cards with MASSIVE debt.
Buyer beware!
Peace out
EOD buying today? Not so much.
This heavily promoted charade is toast.
10% Up today, EOD Buying Continues.
Nasdaq Cometh.
The scam OTC is a-nasty-revelation to many new-traders.
OTC players are most often nefarious and unscrupulous.
CANB is not immune.
Buyer beware.
On the trades tab
There is buy sell and ?
Does anyone know what the ? Is for?
Tks in advance
Easy to see why the small selling group has dwindled down to single digits:
:
Easy to see why the growing interest in CANB, no wonder Accumulation Continues.
I would hate to be one of the few on the sidelines now. CANB continues to make all the right moves. Facts are pretty solid:
:
Lol! Debt to build a massive seed to sale hemp-CBD company coupled with historic year after year revenue gains is a good thing. You have to expand to make the revenues increase and CANB is doing a fantastic job expanding and generating revenue. TSL* has a mind boggling 42 billion dollar "debt" but the company is growing massively.
There's good debt: expanding the company and making huge revenue. CANB example:
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
CANB ship almost completely under water and matter of time. The interest on the debt has to be crushing. Bloated salaries and products that simply sit on shelves or expire.
Not much left here as the ship is all but sunk. Share holders were slaughtered on the multi RS's and killed all value.
Peace out
The CANB minor selling group has dwindled down to the lowly B team. It’s funny to watch.
CANB bagholders groups value is now .0003 after RS's.
Most would need 50.00- 60.00 price here. Hahahahahah never happening just like the NASDAQ BS!
The CANB promo group has dwindled down to the lowly B team. It’s hard to watch.
The interest alone will kill CANB as the debt is so crushing. So bloated salaries, MASSIVE choaking debt and products that seem no one want.
Who would burn money in this mess? True value after the poast few RS is .0003 and going down.
Peace out
Easy to see why the growing interest in CANB, no wonder Accumulation Continues.
I would hate to be one of the few on the sidelines now. CANB continues to make all the right moves. Facts are pretty solid:
:
Lol! Debt to build a massive seed to sale hemp-CBD company coupled with historic year after year revenue gains is a good thing. You have to expand to make the revenues increase and CANB is doing a fantastic job expanding and generating revenue. TSL* has a mind boggling 42 billion dollar "debt" but the company is growing massively.
There's good debt: expanding the company and making huge revenue. CANB example:
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Ummm recovery? Lucky CANB is still trading with the MASSIVE debt, bloated salaries and products that seem few want.
Please all look at the past few RS's that took out all share holders and this is now a slow bleed.
Peace out
I find the CANB debacle funny as well.
I know right, stocks go down and up daily. Inexperience to point out a down day when CANB has been going up almost daily, lol.
:
Watch the recovery Friday. Funny watching the critics jump all over a desperate seller. LMAO! Quite amusing
NASDAQ
CANB
Watch the recovery Friday. Funny watching the critics jump all over a desperate seller. LMAO! Quite amusing
NASDAQ
CANB
The Badguy
Only in CANBland is “down 20%” a great day with buying EOD.
Dude,,, DUMPFEST end of day, down 20%. The lifeboats are in the water for this sinking ship.
Look at the mess CANB is in. They cannot substain the interest of the MASSIVE debt they have now. Salaries out of control and no one wants the crappy products.
Maybe another RS to help take this to .0000001. LOL
Maybe you posted on the wrong board?
Peace out
Some getting desperate with CANB and taking what they can. CANB 1K buys and 13K sell.
https://ih.advfn.com/stock-market/USOTC/can-b-qb-CANB/trades
Have no idea how CANB is still open. Maybe another RS is in CANB future. LOL
Yep, agree Smart Money Continues to Accumulate Daily EOD.
Nasdaq Cometh.
Once again loading end of day
NASDAQ
CANB
The Badguy
Crushing debt, bloated salaries and a product no one wants. CANB is a house of cards and surprised it made it this far.
Great day for this overhyped garbage.
Only down 11%.
Lol truth! CANB going to NASDAQ is also truth!
CANB
The Badguy
Good to see Smart Investors don’t listen to years old negative opinions.
Next stop 6 month high, then yearly high.
First Quarter Revenue Growth-of 606% speaks volumes.
No denying it, Daily Accumulation Continues.
Those numbers will not cover interest on the MASSIVE CANB debt. CANB is cooked, stick a fork in it. Seen it coming years ago and 2 RS's later, time is finally up for this trainwreck. Mark it!
Peace out
Misleading IMO, that has been said years ago. Yet CANB Continues to Grow and Expand it’s Growing Business Successfully.
Nothing better then Facts to prove CANB’s Continued Success in the industry.
Accumulation Continues Daily:
Best to Provide Facts on CANB Continued Growth and Expansion.....Just can't Trick Smart Money From Continued Accumulation Daily. Next Stop 6 Month High on the Chart.
Looks like EOD Accumulation Continued All week again. Goes to show CANB Fun to watch 2022...And Beyond. Smart Money knows CANB is making all the right moves, This is a big part why:
THE HIGHEST QUARTERLY REVENUE IN COMPANY HISTORY, Very Impressive Indeed:
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
May 18 2022 - 07:26AM
InvestorsHub NewsWire
Alert
Print
Share On Facebook
Strengthened Balance Sheet with Increases to $17.0 Million in Total Assets and $6.2 Million in Stockholders Equity
CANB CBD is done, over and stick a fork in the bloated pig. No NASDAQ and all BS from this trainwreck. They cannot stay afloat with the MASSIVE debt much longer.
Peace out
Spot On BG, boy I would hate to be one of the few on the sidelines now. CANB continues to make all the right moves. Facts are pretty solid:
:
Lol! Debt to build a massive seed to sale hemp-CBD company coupled with historic year after year revenue gains is a good thing. You have to expand to make the revenues increase and CANB is doing a fantastic job expanding and generating revenue. TSL* has a mind boggling 42 billion dollar "debt" but the company is growing massively.
There's good debt: expanding the company and making huge revenue. CANB example:
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Lol! Debt to build a massive seed to sale hemp-CBD company coupled with historic year after year revenue gains is a good thing. You have to expand to make the revenues increase and CANB is doing a fantastic job expanding and generating revenue. TSL* has a mind boggling 42 billion dollar "debt" but the company is growing massively.
There's good debt: expanding the company and making huge revenue. CANB example:
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
And bad debt: basically just look at the federal government's spending
CANB is definitely NOT the US government
NASDAQ
CANB
The Badguy
Hey WC,,, Amazing CANB is still trading as the debt has to be so crushing and building to a boiling point soon. It is a mess, that is for sure.
Peace out
Hard to watch what’s happened to the CANB promo.
Simple question. What is share holders value after the RS's? It is .0003 and all are burried deep in this bloated pig. The price would have to go to 45.00-50.00 for many to get back to even. NEVER EVER, EVER happening as this is clearly a house of cards.
NASDAQ is not happening. No one wants the products any longer and that was shown why years ago.
Peace out
Followers
|
285
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
30513
|
Created
|
06/18/11
|
Type
|
Free
|
Moderators waterchaser |
These brands include Canbiola, developed for the medical community, Seven Chakras, a spa line, NuWellness for independent Pharmacies and Pure Leaf Oil, their flagship consumer brand.
A growing line of other consumer products are also being developed, with exclusive partner agreements, to sell topical topicals, beverages and ingestible products under the LifeGuard® Brand. The company is launching a full line of Sunscreens, Lip Balms, Replenish Supplements and Water in the summer of 2020. In addition, a line of nutritional supplements called Superfoods, is being readied for a launch at the same time.
Their R&D and production facility is in Lacey WA. There they create, tests, and with a proprietary processes, produce the company’s CBD line of products and private label products to the industry’s highest standards.
CanB owns and operates Green Grow Farms, which is licensed to grow and cultivate Hemp in the State of New York.
Through the Duramed Division, the company offers FDA approved medical devices that alleviate joint, bone and muscle pain from injuries and surgery. Sold through doctors and the medical community, they are considered an important part of the solution to solving the opioid crisis.
http://www.canbcorp.com/
https://canbiola.com
https://duramed.us
https://www.otcmarkets.com/stock/CANB/security
Canbiola, Inc. (OTCQB: CANB) Announces the Formation of a New Wholly Owned Subsidiary- DuraMed, Inc
https://duramed.us
https://www.otcmarkets.com/stock/CANB/news/Canbiola-Inc-OTCQB-CANB-Announces-the-Formation-of-a-New-Wholly-Owned-Subsidiary--DuraMed-Inc?id=216443
SUSTAINED ACOUSTIC MEDICINE (SAMS)
Duramed provides wearable bioelectronic devices for the delivery of sustained acoustic medicine (SAMs). The proprietary miniaturized ultrasound platform is designed for the treatment of acute and chronic musculoskeletal conditions, and clinically proven to enhance tissue recovery, accelerate the natural healing processes, and relieve pain.
The SAM® family of products are the only FDA-cleared wearable devices for multi-hour continuous low intensity ultrasound therapy. SAM has a CE Mark, Canada Licensed, and is a Class II medical device in Malaysia and Singapore.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |